Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Small Molecule Activator of the TET2 Tumor Suppressor

ABSTRACT: A Small Molecule Activator of the TET2 Tumor Suppressor

PROVIDER: PRJNA497516 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8079440_1.fastq.gz	Fastqsanger.gz
	SRR8079440_2.fastq.gz	Fastqsanger.gz
	SRR8079450_1.fastq.gz	Fastqsanger.gz
	SRR8079450_2.fastq.gz	Fastqsanger.gz
	SRR8079460_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

A Small Molecule Activator of the TET2 Tumor Suppressor

Project description:TET2 protein is a dioxygenase that oxidizes 5-methylcytosine and is responsible for DNA demethylation. We found that a small molecule drug (3FM-dC) activates the enzyme activity of TET2. The sequencing data suggest that 3FM-dC induced global changes in DNA hydroxymethylation and gene expression.

2022-10-18 | GSE121506 | GEO

Small molecule TERT activator prevents aging and cognitive decline [ChIP-seq]

Project description:Small molecule TERT activator prevents aging and cognitive decline [ChIP-seq]

| PRJNA966085 | ENA

Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction With the Small Molecule iKIX1

Project description:Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction With the Small Molecule iKIX1

| PRJNA299815 | ENA

Small molecule TERT activator prevents aging and cognitive decline [ChIP-seq]

Project description:We discovered a novel small-molecule TERT activating compound (TAC) that selectively enhances TERT transcription in human and mouse adult somatic cells. Our findings also provide the novel mechanism of TAC-mediated TERT up-regulation and elucidate the impact of TERT induction on regulatory factors governing aging.

2024-05-14 | GSE231455 | GEO

Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction With the Small Molecule iKIX1

Project description:Eukaryotic transcription activators stimulate the expression of specific sets of target genes through recruitment of co-activators such as the RNA polymerase II-interacting Mediator complex. We previously identified an activator-targeted ~85 amino acid three-helix bundle KIX domain in the human MED15 Mediator subunit that is structurally conserved in Gal11 Mediator subunits in fungi. The Gal11 KIX domain is engaged by pleiotropic drug resistance transcription factor (Pdr1) orthologues, key regulators of the multidrug resistance (MDR) pathway in S. cerevisiae and in the clinically important human pathogen Candida glabrata. Drug-resistant clinical isolates of C. glabrata most commonly harbour point mutations in Pdr1 that render it constitutively active, suggesting that this transcriptional activation pathway may represent a lynchpin in C. glabrata MDR. We have now carried out sequential biochemical and in vivo high-throughput screens to identify small molecule inhibitors of the interaction of the C. glabrata Pdr1 activation domain with the C. glabrata Gal11A KIX domain. The lead compound (iKIX1) inhibits Pdr1-dependent gene activation in both S. cerevisiae and C. glabrata and re-sensitizes drug-resistant C. glabrata to effective azole antifungal concentrations in vitro and in animal models for disseminated and urinary tract C. glabrata infection. Samples are generated in triplicate for four conditions (DMSO/vehicle-treated, iKIX1-treated, DMSO/vehicle and ketoconazole-treated. and iKIX1-ketoconazole treated) in both Saccharomyces cerevisiae and Candida glabrata

2015-12-15 | E-GEOD-74361 | biostudies-arrayexpress

Single cell RNA sequencing of human induced pluripotent stem cell-derived cardiomyocytes with or without small molecule activation of FOXO signaling

Project description:We treated differentiated iPSC-derived cardiomyocytes with a small molecule FOXO activator to to evaluate potential genes that might facilitate cardiomyocyte maturation.

2024-08-09 | GSE190742 | GEO

Tpl-2 and MEK small molecule inhibitors

Project description:Tpl-2 and MEK small molecule inhibitors

| PRJNA328166 | ENA

Mycobacterium tuberculosis transcriptional response to small molecule

Project description:Mycobacterium tuberculosis transcriptional response to small molecule

| PRJNA523038 | ENA

Phosphoproteomics Profiling of Non-Small Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator

Project description:Activation of protein phosphatase 2A (PP2A) is a promising anti-cancer therapeutic strategy given this tumor suppressor’s ability to coordinately downregulate multiple pathways involved with growth and proliferation.Here, we studied the global signaling response signature of a novel small molecule activator of PP2A (SMAP). Through an exploration of the global phosphoproteomicalterations of two KRAS mutated non-small cell lung cancer (NSCLC) cell lines (A549 and H358)in the context of PP2A activation, we sought to identify the pathway-level perturbations and uncover candidate proteins that are potentially key targets of SMAP regulation.

2018-07-05 | PXD005698 | Pride

Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction With the Small Molecule iKIX1

2015-12-15 | GSE74361 | GEO